Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-02-06T17:45:25.078Z Has data issue: false hasContentIssue false

The role of tissue plasminogen activator in the successful treatment of infected cardiac thrombus in children

Published online by Cambridge University Press:  15 August 2006

Eli Zalzstein
Affiliation:
Pediatric Cardiology Unit, Cardiology Department, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion, University of the Negev, Beer Sheva, Israel
Nili Zucker
Affiliation:
Pediatric Cardiology Unit, Cardiology Department, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion, University of the Negev, Beer Sheva, Israel
Aviva Levitas
Affiliation:
Pediatric Cardiology Unit, Cardiology Department, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion, University of the Negev, Beer Sheva, Israel
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Infected cardiac thrombus is rare in children, with antibiotic or antifungal agents used as the first line of treatment. Persistence is an indication for surgical intervention. We describe two children who were treated successfully with a combination of antibiotic and antithrombotic agents. Use of antithrombotic agents promotes degeneration of fibrin, thus reducing the mass and facilitating the diffusion of the antibiotic and/or antifungal agents.

Type
Brief Report
Copyright
2001 Cambridge University Press